VRCA — VERRICA PHARMACEUTICALS INC (Healthcare >> Biotechnology)
VRCA FAQ
What is VRCA's P/E ratio?
VERRICA PHARMACEUTICALS INC (VRCA) currently trades at a P/E ratio of 515.36.
What is VRCA's ROE?
VERRICA PHARMACEUTICALS INC reports a Return on Equity (ROE) of -111.03%.
What is VRCA's dividend yield?
VERRICA PHARMACEUTICALS INC offers a dividend yield of 0.00%.
What is VRCA's Deepscope Quality Score?
Deepscope rates VRCA's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy VRCA?
Deepscope's AI Timing Score for VRCA is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does VRCA belong to?
VERRICA PHARMACEUTICALS INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 5.75
Price
-0.37
(-6.05%)
Day Change
|
|
|---|
VRCA Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 46) và Thời điểm mua ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
Tỷ lệ P/E tương đối cao
Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
Tăng trưởng ROE là âm trong năm ngoái.
ROE đang giảm đáng kể
Tăng trưởng ROA hiện tại đang dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Lịch sử Biên lợi nhuận ròng tương đối thấp.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Khá , ...
| Yếu tố Chất lượng |
|
48% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 5.75 |
| PBV / Sector |
6.55 / 4.79
|
| Earning Per Share | -0.97 |
| PE / Sector |
515.36 / 17.89
|
| PEG or PE/Growth / Sector |
88.10 / 0.56
|
| Average 1M Daily Value |
0.34 M
GREAT
|
| Average 1W Daily Value |
0.27 M
GREAT
|
| Yếu tố Kỹ thuật |
|
14% |
| Sức khỏe tài chính |
|
41% |
| Khả năng kiếm lợi nhuận |
|
64% |
| Lợi tức cho nhà đầu tư |
|
4% |
| Chi tiết đăng ký |
| Analyze Date | 2026-06-11 09:54:49 |
| Symbol | VRCA |
| Name | VERRICA PHARMACEUTICALS INC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 17.18 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 105.13 / 8,963.32 |
| Tin tức, Dự báo ước tính |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 44 West Gay Street, West Chester, PA, United States, 19380
Phone: 484 453 3300
Website: https://www.verrica.com
Employees: 76
Sector: Healthcare >> Biotechnology
Description: Verrica Pharmaceuticals Inc., a dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States. The company offers YCANTH (VP-102) a drug-device combination that contains a GMP-controlled formulation of cantharidin for the treatment of molluscum in adult and pediatric patients, as well as for the treatment of common warts. It also develops VP-315, an oncolytic peptide-based injectable therapy that is in phase II clinical trial for the treatment of dermatology oncologic conditions, which include basal cell carcinoma and other dermatological oncology indications. The company has a collaboration and license agreement with Torii Pharmaceutical Co., Ltd. for the development and commercialization of its product candidates for the treatment of molluscum and common warts in Japan; and a license agreement with Lytix Biopharma AS to develop and commercialize VP-315 for use in malignant and pre-malignant dermatological indications. Verrica Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in West Chester, Pennsylvania.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
Google